Global Connected Injectable Drug Delivery Devices Market Research Report 2020

Publisher Name :
Date: 06-Feb-2020
No. of pages: 116
Inquire Before Buying

Connected injectable drug delivery devices reminds and records patients dosing pattern and makes it accessible to healthcare professionals for significant understanding about the patient condition.

Growing prevalence of chronic diseases like diabetes, cardiovascular disease, and cancer coupled with increasing compliance to the treatment owing to use of the Connected injectable drug delivery devices.

Market Analysis and Insights: Global Connected Injectable Drug Delivery Devices Market

The global Connected Injectable Drug Delivery Devices market is valued at xx million US$ in 2020 is expected to reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2021-2026.

Global Connected Injectable Drug Delivery Devices Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market's growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and also about each type from 2015 to 2026. This section mentions the volume of production by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert's opinions have been taken to understand the market better.

Market Segment Analysis

The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Conventional

- Self-Injection

- Others

Segment by Application

- Diabetes

- Cardiovascular Diseases

- Autoimmune Diseases

- Hormones Replacement

- Neurology

- Addiction

- Respiratory Diseases

- Others

Global Connected Injectable Drug Delivery Devices Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the Connected Injectable Drug Delivery Devices market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Connected Injectable Drug Delivery Devices Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

The major players in the market include Phillips-Medisize, West Pharmaceutical Services, Biocorp, Aterica, Unilife, Propeller Health, Haselmeier, SHL, Becton Dickinson, Baxter International, Scandinavian Health, Ypsomed, Terumo Medical, Schott, Owen Mumford, Antares Pharma, Zogenix, etc.

Global Connected Injectable Drug Delivery Devices Market Research Report 2020

Table of Contents
1 Connected Injectable Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Connected Injectable Drug Delivery Devices
1.2 Connected Injectable Drug Delivery Devices Segment by Type
1.2.1 Global Connected Injectable Drug Delivery Devices Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Conventional
1.2.3 Self-Injection
1.2.4 Others
1.3 Connected Injectable Drug Delivery Devices Segment by Application
1.3.1 Connected Injectable Drug Delivery Devices Consumption Comparison by Application: 2020 VS 2026
1.3.2 Diabetes
1.3.3 Cardiovascular Diseases
1.3.4 Autoimmune Diseases
1.3.5 Hormones Replacement
1.3.6 Neurology
1.3.7 Addiction
1.3.8 Respiratory Diseases
1.3.9 Others
1.4 Global Connected Injectable Drug Delivery Devices Market by Region
1.4.1 Global Connected Injectable Drug Delivery Devices Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Global Connected Injectable Drug Delivery Devices Growth Prospects
1.5.1 Global Connected Injectable Drug Delivery Devices Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Connected Injectable Drug Delivery Devices Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Connected Injectable Drug Delivery Devices Production Estimates and Forecasts (2015-2026)
2 Market Competition by Manufacturers
2.1 Global Connected Injectable Drug Delivery Devices Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Connected Injectable Drug Delivery Devices Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Connected Injectable Drug Delivery Devices Production Sites, Area Served, Product Types
2.6 Connected Injectable Drug Delivery Devices Market Competitive Situation and Trends
2.6.1 Connected Injectable Drug Delivery Devices Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Connected Injectable Drug Delivery Devices Market Share by Regions (2015-2020)
3.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Regions (2015-2020)
3.3 Global Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Connected Injectable Drug Delivery Devices Production
3.4.1 North America Connected Injectable Drug Delivery Devices Production Growth Rate (2015-2020)
3.4.2 North America Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Connected Injectable Drug Delivery Devices Production
3.5.1 Europe Connected Injectable Drug Delivery Devices Production Growth Rate (2015-2020)
3.5.2 Europe Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Connected Injectable Drug Delivery Devices Production
3.6.1 China Connected Injectable Drug Delivery Devices Production Growth Rate (2015-2020)
3.6.2 China Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan Connected Injectable Drug Delivery Devices Production
3.7.1 Japan Connected Injectable Drug Delivery Devices Production Growth Rate (2015-2020)
3.7.2 Japan Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Connected Injectable Drug Delivery Devices Consumption by Regions
4.1 Global Connected Injectable Drug Delivery Devices Consumption by Regions
4.1.1 Global Connected Injectable Drug Delivery Devices Consumption by Region
4.1.2 Global Connected Injectable Drug Delivery Devices Consumption Market Share by Region
4.2 North America
4.2.1 North America Connected Injectable Drug Delivery Devices Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Connected Injectable Drug Delivery Devices Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Connected Injectable Drug Delivery Devices Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Connected Injectable Drug Delivery Devices Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
5.1 Global Connected Injectable Drug Delivery Devices Production Market Share by Type (2015-2020)
5.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Type (2015-2020)
5.3 Global Connected Injectable Drug Delivery Devices Price by Type (2015-2020)
5.4 Global Connected Injectable Drug Delivery Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 Global Connected Injectable Drug Delivery Devices Market Analysis by Application
6.1 Global Connected Injectable Drug Delivery Devices Consumption Market Share by Application (2015-2020)
6.2 Global Connected Injectable Drug Delivery Devices Consumption Growth Rate by Application (2015-2020)
7 Company Profiles and Key Figures in Connected Injectable Drug Delivery Devices Business
7.1 Phillips-Medisize
7.1.1 Phillips-Medisize Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.1.2 Phillips-Medisize Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Phillips-Medisize Main Business and Markets Served
7.2 West Pharmaceutical Services
7.2.1 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.2.2 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 West Pharmaceutical Services Main Business and Markets Served
7.3 Biocorp
7.3.1 Biocorp Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.3.2 Biocorp Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.3.3 Biocorp Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Biocorp Main Business and Markets Served
7.4 Aterica
7.4.1 Aterica Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.4.2 Aterica Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.4.3 Aterica Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Aterica Main Business and Markets Served
7.5 Unilife
7.5.1 Unilife Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.5.2 Unilife Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.5.3 Unilife Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Unilife Main Business and Markets Served
7.6 Propeller Health
7.6.1 Propeller Health Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.6.2 Propeller Health Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.6.3 Propeller Health Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Propeller Health Main Business and Markets Served
7.7 Haselmeier
7.7.1 Haselmeier Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.7.2 Haselmeier Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.7.3 Haselmeier Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.7.4 Haselmeier Main Business and Markets Served
7.8 SHL
7.8.1 SHL Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.8.2 SHL Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.8.3 SHL Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 SHL Main Business and Markets Served
7.9 Becton Dickinson
7.9.1 Becton Dickinson Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.9.2 Becton Dickinson Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 Becton Dickinson Main Business and Markets Served
7.10 Baxter International
7.10.1 Baxter International Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.10.2 Baxter International Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.10.3 Baxter International Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 Baxter International Main Business and Markets Served
7.11 Scandinavian Health
7.11.1 Scandinavian Health Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.11.2 Scandinavian Health Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.11.3 Scandinavian Health Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 Scandinavian Health Main Business and Markets Served
7.12 Ypsomed
7.12.1 Ypsomed Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.12.2 Ypsomed Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.12.3 Ypsomed Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 Ypsomed Main Business and Markets Served
7.13 Terumo Medical
7.13.1 Terumo Medical Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.13.2 Terumo Medical Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.13.3 Terumo Medical Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.13.4 Terumo Medical Main Business and Markets Served
7.14 Schott
7.14.1 Schott Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.14.2 Schott Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.14.3 Schott Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.14.4 Schott Main Business and Markets Served
7.15 Owen Mumford
7.15.1 Owen Mumford Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.15.2 Owen Mumford Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.15.3 Owen Mumford Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.15.4 Owen Mumford Main Business and Markets Served
7.16 Antares Pharma
7.16.1 Antares Pharma Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.16.2 Antares Pharma Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.16.3 Antares Pharma Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.16.4 Antares Pharma Main Business and Markets Served
7.17 Zogenix
7.17.1 Zogenix Connected Injectable Drug Delivery Devices Production Sites and Area Served
7.17.2 Zogenix Connected Injectable Drug Delivery Devices Product Introduction, Application and Specification
7.17.3 Zogenix Connected Injectable Drug Delivery Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.17.4 Zogenix Main Business and Markets Served
8 Connected Injectable Drug Delivery Devices Manufacturing Cost Analysis
8.1 Connected Injectable Drug Delivery Devices Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Connected Injectable Drug Delivery Devices
8.4 Connected Injectable Drug Delivery Devices Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Connected Injectable Drug Delivery Devices Distributors List
9.3 Connected Injectable Drug Delivery Devices Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 Production and Supply Forecast
11.1 Global Forecasted Production of Connected Injectable Drug Delivery Devices (2021-2026)
11.2 Global Forecasted Revenue of Connected Injectable Drug Delivery Devices (2021-2026)
11.3 Global Forecasted Price of Connected Injectable Drug Delivery Devices (2021-2026)
11.4 Global Connected Injectable Drug Delivery Devices Production Forecast by Regions (2021-2026)
11.4.1 North America Connected Injectable Drug Delivery Devices Production, Revenue Forecast (2021-2026)
11.4.2 Europe Connected Injectable Drug Delivery Devices Production, Revenue Forecast (2021-2026)
11.4.3 China Connected Injectable Drug Delivery Devices Production, Revenue Forecast (2021-2026)
11.4.4 Japan Connected Injectable Drug Delivery Devices Production, Revenue Forecast (2021-2026)
12 Consumption and Demand Forecast
12.1 Global Forecasted and Consumption Demand Analysis of Connected Injectable Drug Delivery Devices
12.2 North America Forecasted Consumption of Connected Injectable Drug Delivery Devices by Country
12.3 Europe Market Forecasted Consumption of Connected Injectable Drug Delivery Devices by Country
12.4 Asia Pacific Market Forecasted Consumption of Connected Injectable Drug Delivery Devices by Regions
12.5 Latin America Forecasted Consumption of Connected Injectable Drug Delivery Devices
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Connected Injectable Drug Delivery Devices by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Connected Injectable Drug Delivery Devices by Type (2021-2026)
13.1.2 Global Forecasted Price of Connected Injectable Drug Delivery Devices by Type (2021-2026)
13.2 Global Forecasted Consumption of Connected Injectable Drug Delivery Devices by Application (2021-2026)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global Connected Injectable Drug Delivery Devices Production (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Connected Injectable Drug Delivery Devices Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 3. Global Connected Injectable Drug Delivery Devices Consumption (K Units) Comparison by Application: 2020 VS 2026
Table 4. Global Connected Injectable Drug Delivery Devices Production (K Units) by Manufacturers
Table 5. Global Connected Injectable Drug Delivery Devices Production (K Units) by Manufacturers (2015-2020)
Table 6. Global Connected Injectable Drug Delivery Devices Production Share by Manufacturers (2015-2020)
Table 7. Global Connected Injectable Drug Delivery Devices Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers (2015-2020)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Connected Injectable Drug Delivery Devices as of 2019)
Table 10. Global Market Connected Injectable Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 11. Manufacturers Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 12. Manufacturers Connected Injectable Drug Delivery Devices Product Types
Table 13. Global Connected Injectable Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Connected Injectable Drug Delivery Devices Capacity (K Units) by Region (2015-2020)
Table 16. Global Connected Injectable Drug Delivery Devices Production (K Units) by Region (2015-2020)
Table 17. Global Connected Injectable Drug Delivery Devices Revenue (Million US$) by Region (2015-2020)
Table 18. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2015-2020)
Table 19. Global Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 20. North America Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 21. Europe Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 22. China Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 23. Japan Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 24. Global Connected Injectable Drug Delivery Devices Consumption (K Units) Market by Region (2015-2020)
Table 25. Global Connected Injectable Drug Delivery Devices Consumption Market Share by Region (2015-2020)
Table 26. North America Connected Injectable Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 27. Europe Connected Injectable Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 28. Asia Pacific Connected Injectable Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 29. Latin America Connected Injectable Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 30. Global Connected Injectable Drug Delivery Devices Production (K Units) by Type (2015-2020)
Table 31. Global Connected Injectable Drug Delivery Devices Production Share by Type (2015-2020)
Table 32. Global Connected Injectable Drug Delivery Devices Revenue (Million US$) by Type (2015-2020)
Table 33. Global Connected Injectable Drug Delivery Devices Revenue Share by Type (2015-2020)
Table 34. Global Connected Injectable Drug Delivery Devices Price (USD/Unit) by Type (2015-2020)
Table 35. Global Connected Injectable Drug Delivery Devices Consumption (K Units) by Application (2015-2020)
Table 36. Global Connected Injectable Drug Delivery Devices Consumption Market Share by Application (2015-2020)
Table 37. Global Connected Injectable Drug Delivery Devices Consumption Growth Rate by Application (2015-2020)
Table 38. Phillips-Medisize Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 39. Phillips-Medisize Production Sites and Area Served
Table 40. Phillips-Medisize Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 41. Phillips-Medisize Main Business and Markets Served
Table 42. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 43. West Pharmaceutical Services Production Sites and Area Served
Table 44. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 45. West Pharmaceutical Services Main Business and Markets Served
Table 46. Biocorp Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 47. Biocorp Production Sites and Area Served
Table 48. Biocorp Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 49. Biocorp Main Business and Markets Served
Table 50. Aterica Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 51. Aterica Production Sites and Area Served
Table 52. Aterica Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 53. Aterica Main Business and Markets Served
Table 54. Unilife Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 55. Unilife Production Sites and Area Served
Table 56. Unilife Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 57. Unilife Main Business and Markets Served
Table 58. Propeller Health Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 59. Propeller Health Production Sites and Area Served
Table 60. Propeller Health Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Propeller Health Main Business and Markets Served
Table 62. Haselmeier Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 63. Haselmeier Production Sites and Area Served
Table 64. Haselmeier Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 65. Haselmeier Main Business and Markets Served
Table 66. SHL Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 67. SHL Production Sites and Area Served
Table 68. SHL Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. SHL Main Business and Markets Served
Table 70. Becton Dickinson Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 71. Becton Dickinson Production Sites and Area Served
Table 72. Becton Dickinson Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Becton Dickinson Main Business and Markets Served
Table 74. Baxter International Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 75. Baxter International Production Sites and Area Served
Table 76. Baxter International Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Baxter International Main Business and Markets Served
Table 78. Scandinavian Health Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 79. Scandinavian Health Production Sites and Area Served
Table 80. Scandinavian Health Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Scandinavian Health Main Business and Markets Served
Table 82. Ypsomed Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 83. Ypsomed Production Sites and Area Served
Table 84. Ypsomed Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Ypsomed Main Business and Markets Served
Table 86. Terumo Medical Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 87. Terumo Medical Production Sites and Area Served
Table 88. Terumo Medical Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Terumo Medical Main Business and Markets Served
Table 90. Schott Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 91. Schott Production Sites and Area Served
Table 92. Schott Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Schott Main Business and Markets Served
Table 94. Owen Mumford Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 95. Owen Mumford Production Sites and Area Served
Table 96. Owen Mumford Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Owen Mumford Main Business and Markets Served
Table 98. Antares Pharma Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 99. Antares Pharma Production Sites and Area Served
Table 100. Antares Pharma Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Antares Pharma Main Business and Markets Served
Table 102. Zogenix Connected Injectable Drug Delivery Devices Production Sites and Area Served
Table 103. Zogenix Production Sites and Area Served
Table 104. Zogenix Connected Injectable Drug Delivery Devices Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Zogenix Main Business and Markets Served
Table 106. Production Base and Market Concentration Rate of Raw Material
Table 107. Key Suppliers of Raw Materials
Table 108. Connected Injectable Drug Delivery Devices Distributors List
Table 109. Connected Injectable Drug Delivery Devices Customers List
Table 110. Market Key Trends
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Global Connected Injectable Drug Delivery Devices Production (K Units) Forecast by Region (2021-2026)
Table 114. North America Connected Injectable Drug Delivery Devices Consumption Forecast 2021-2026 (K Units) by Country
Table 115. Europe Connected Injectable Drug Delivery Devices Consumption Forecast 2021-2026 (K Units) by Country
Table 116. Asia Pacific Connected Injectable Drug Delivery Devices Consumption Forecast 2021-2026 (K Units) by Regions
Table 117. Latin America Connected Injectable Drug Delivery Devices Consumption Forecast 2021-2026 (K Units) by Country
Table 118. Global Connected Injectable Drug Delivery Devices Consumption (K Units) Forecast by Regions (2021-2026)
Table 119. Global Connected Injectable Drug Delivery Devices Production (K Units) Forecast by Type (2021-2026)
Table 120. Global Connected Injectable Drug Delivery Devices Revenue (Million US$) Forecast by Type (2021-2026)
Table 121. Global Connected Injectable Drug Delivery Devices Price (USD/Unit) Forecast by Type (2021-2026)
Table 122. Global Connected Injectable Drug Delivery Devices Consumption (K Units) Forecast by Application (2021-2026)
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Connected Injectable Drug Delivery Devices
Figure 2. Global Connected Injectable Drug Delivery Devices Production Market Share by Type: 2020 VS 2026
Figure 3. Conventional Product Picture
Figure 4. Self-Injection Product Picture
Figure 5. Others Product Picture
Figure 6. Global Connected Injectable Drug Delivery Devices Consumption Market Share by Application: 2020 VS 2026
Figure 7. Diabetes
Figure 8. Cardiovascular Diseases
Figure 9. Autoimmune Diseases
Figure 10. Hormones Replacement
Figure 11. Neurology
Figure 12. Addiction
Figure 13. Respiratory Diseases
Figure 14. Others
Figure 15. North America Connected Injectable Drug Delivery Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 16. Europe Connected Injectable Drug Delivery Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 17. China Connected Injectable Drug Delivery Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 18. Japan Connected Injectable Drug Delivery Devices Revenue (Million US$) and Growth Rate (2015-2026)
Figure 19. Global Connected Injectable Drug Delivery Devices Revenue (Million US$) (2015-2026)
Figure 20. Global Connected Injectable Drug Delivery Devices Production Capacity (K Units) (2015-2026)
Figure 21. Connected Injectable Drug Delivery Devices Production Share by Manufacturers in 2019
Figure 22. Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers in 2019
Figure 23. Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Market Connected Injectable Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers in 2019
Figure 25. The Global 5 and 10 Largest Players: Market Share by Connected Injectable Drug Delivery Devices Revenue in 2019
Figure 26. Global Connected Injectable Drug Delivery Devices Production Market Share by Region (2015-2020)
Figure 27. Global Connected Injectable Drug Delivery Devices Production Market Share by Region in 2019
Figure 28. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2015-2020)
Figure 29. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region in 2019
Figure 30. Global Connected Injectable Drug Delivery Devices Production (K Units) Growth Rate (2015-2020)
Figure 31. North America Connected Injectable Drug Delivery Devices Production (K Units) Growth Rate (2015-2020)
Figure 32. Europe Connected Injectable Drug Delivery Devices Production (K Units) Growth Rate (2015-2020)
Figure 33. China Connected Injectable Drug Delivery Devices Production (K Units) Growth Rate (2015-2020)
Figure 34. Japan Connected Injectable Drug Delivery Devices Production (K Units) Growth Rate (2015-2020)
Figure 35. Global Connected Injectable Drug Delivery Devices Consumption Market Share by Region (2015-2020)
Figure 36. Global Connected Injectable Drug Delivery Devices Consumption Market Share by Region in 2019
Figure 37. North America Connected Injectable Drug Delivery Devices Consumption Growth Rate (2015-2020) (K Units)
Figure 38. North America Connected Injectable Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 3
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs